Showing results (81-90 of 383) with videos related to

Sort By:
Pageof 39
International Journal of Surgical Pathology|July 7, 2009
Thyroid transcription factor-1 and "basal marker"--expressing small cell carcinoma of the breastCagatay Ersahin, Sudeshna Bandyopadhyay, Rohit Bhargava
American Journal of Clinical Pathology|April 22, 2005
Chromogenic in situ hybridization for the detection of HER-2/neu gene amplification in breast cancer with an emphasis on tumors with borderline and low-level amplification: does it measure up to fluorescence in situ hybridization?Rohit Bhargava, Priti Lal, Beiyun Chen
Applied Spectroscopy|April 20, 2021
Design Considerations for Discrete Frequency Infrared Microscopy SystemsYamuna Phal, Kevin Yeh, Rohit Bhargava
Cureus|January 10, 2024
Large Solitary Lung Metastasis of a Matrix-Producing Metaplastic Breast Carcinoma: A Diagnostic ChallengeRida Noor, Sigfred Lajara, Rohit Bhargava
Analytical Chemistry|January 4, 2019
Multicolor Discrete Frequency Infrared Spectroscopic ImagingKevin Yeh, Dongkwan Lee, Rohit Bhargava
The Breast Journal|May 6, 2004
Intraoperative cytologic examination of breast sentinel lymph nodes: test utility and patient impactDavid J Dabbs, Mark Fung, Ronald Johnson
Applied Immunohistochemistry & Molecular Morphology : AIMM|August 29, 2020
Best Practice (Efficient) Immunohistologic Panel for Diagnosing Metaplastic Breast CarcinomaMin Han, Huina Zhang, David J Dabbs
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 18, 2016
Intratumor Heterogeneity Affects Gene Expression Profile Test Prognostic Risk Stratification in Early Breast CancerRekha Gyanchandani, Yan Lin, Hui-Min Lin, et al.
Breast Cancer Research and Treatment|August 19, 2015
Developing in vitro models of human ductal carcinoma in situ from primary tissue explantsDaniel D Brown, David J Dabbs, Adrian V Lee, et al.
American Journal of Clinical Pathology|February 27, 2018
Prognostic Significance of Modified Residual Disease in Breast and Nodes (mRDBN) Algorithm After Neoadjuvant Chemotherapy for Breast CancerBeth Z Clark, Daniel J Farrugia, Alessandra Landmann, et al.
Pageof 39